Systemic lupus erythematosus (SLE) is a heterogeneous autoimmune disease with a strong genetic component characterized by autoantibody production and a type I interferon signature 1 . Here we report a missense variant (g.74779296G>A; p.Arg90His) in NCF1, encoding the p47 phox subunit of the phagocyte NADPH oxidase (NOX2), as the putative underlying causal variant that drives a strong SLE-associated signal detected by the Immunochip in the GTF2IRD1-GTF2I region at 7q11.23 with a complex genomic structure. We show that the p.Arg90His substitution, which is reported to cause reduced reactive oxygen species (ROS) production 2 , predisposes to SLE (odds ratio (OR) = 3.47 in Asians (P meta = 3.1 × 10 −104 ), OR = 2.61 in European Americans, OR = 2.02 in African Americans) and other autoimmune diseases, including primary Sjögren's syndrome (OR = 2.45 in Chinese, OR = 2.35 in European Americans) and rheumatoid arthritis (OR = 1.65 in Koreans). Additionally, decreased and increased copy numbers of NCF1 predispose to and protect against SLE, respectively. Our data highlight the pathogenic role of reduced NOX2-derived ROS levels in autoimmune diseases.
Systemic lupus erythematosus (SLE) is a heterogeneous autoimmune disease with a strong genetic component characterized by autoantibody production and a type I interferon signature 1 . Here we report a missense variant (g.74779296G>A; p.Arg90His) in NCF1, encoding the p47 phox subunit of the phagocyte NADPH oxidase (NOX2), as the putative underlying causal variant that drives a strong SLE-associated signal detected by the Immunochip in the GTF2IRD1-GTF2I region at 7q11.23 with a complex genomic structure. We show that the p.Arg90His substitution, which is reported to cause reduced reactive oxygen species (ROS) production 2 , predisposes to SLE (odds ratio (OR) = 3.47 in Asians (P meta = 3.1 × 10 −104 ), OR = 2.61 in European Americans, OR = 2.02 in African Americans) and other autoimmune diseases, including primary Sjögren's syndrome (OR = 2.45 in Chinese, OR = 2.35 in European Americans) and rheumatoid arthritis (OR = 1.65 in Koreans). Additionally, decreased and increased copy numbers of NCF1 predispose to and protect against SLE, respectively. Our data highlight the pathogenic role of reduced NOX2-derived ROS levels in autoimmune diseases.
Dozens of SLE-associated loci have been identified by genome-wide association studies (GWAS) and included on the Immunochip for fine-mapping 3, 4 . Using the Immunochip, we genotyped DNA samples from SLE cases and healthy controls from Chinese, EuropeanAmerican and African-American ancestry groups. In Chinese, the strongest association signal was detected at rs73366469 (minor allele frequency of 28.7% in cases versus 12.6% in controls, P = 3.8 × 10 −29 , OR = 2.88) within the GTF2IRD1-GTF2I intergenic region at 7q11.23 rather than SLE-associated GWAS loci (Fig. 1a) , consistent with another Asian Immunochip study 5 . This association was confirmed in European Americans at a modest significance level (P = 7.5 × 10 −3 , OR = 1.32), but not in African Americans (Supplementary Table 1) .
Because rs73366469 has no strong functional implication (RegulomeDB score = 5) and is not in linkage disequilibrium (LD; r 2 < 0.04) with any Immunochip SNP, we hypothesized that the underlying causal variant(s) were not on the Immunochip and were in strong, modest and weak LD with rs73366469 in Chinese, European Americans and African Americans, respectively. In the 1000 Genomes Project data set, we found two non-Immunochip SNPs (rs117026326 and rs12667901) that were in stronger LD with rs73366469 in Asians than in Europeans and Africans ( Fig. 1 and Supplementary Table 2) . In a subset of Chinese and European-American subjects genotyped using the Immunochip (Chinese-1 and EurAm-1) and independent replication data sets (Chinese-2 and EurAm-2), rs117026326, located in intron 9 of GTF2I, exhibited stronger association with SLE (P meta Chinese = 4.4 × 10 −40 , OR = 2.94; P meta EurAm = 1.2 × 10 −4 , OR = 2.83; Supplementary Tables 3 and 4) than rs73366469 and rs12667901, and conditioning on rs117026326 rather than rs73366469 or rs12667901 eliminated association signals for the other two SNPs, suggesting that association of rs73366469 with SLE might be attributed to rs117026326. However, rs117026326 was nearly non-polymorphic in African Americans and was not associated with SLE (Supplementary Located 62 kb from rs117026326 is NCF1 (neutrophil cytosolic factor 1), encoding the regulatory p47 phox subunit necessary for activation of the phagocytic NOX2 complex, which is likely an SLE-related gene because nonfunctional NOX2 exacerbates lupus features in lupusprone MRL.Fas lpr mice and induces a lupus-like type I interferon signature, autoantibody production and immune complex deposition in the kidneys of BALB/c.Ncf1 m1J mice 6, 7 ; NCF2, encoding another NOX2 regulatory subunit, p67 phox , harbors the missense variant p.His389Gln that is associated with SLE risk in European Americans 8 . However, rs117026326 genotype was not associated with the transcript levels of NCF1 or two other neighboring genes, GTF2I and GTF2IRD1, in the peripheral blood mononuclear cells (PBMCs) of patients with SLE and healthy controls (Supplementary Fig. 1) . Notably, the NCF1 region is barely covered by variants in the 1000 Genomes Project Phase 1 data set (Fig. 1a) , probably because NCF1 has 98% sequence identity with the nonfunctional pseudogenes NCF1B and NCF1C at 7q11.23 that are located within large DNA duplications 9 (Figs. 1b and 2a) . The strong association of rs117026326 with SLE and functional implication of NCF1 led us to further hypothesize that rs117026326 might tag causal variant(s) of NCF1 not present in the 1000 Genomes Project.
The GTGT sequence within exon 2 of NCF1 is a well-characterized variant that distinguishes this gene from NCF1B and NCF1C, which contain a GT deletion (∆GT) 10 (Fig. 2b) . However, reciprocal crossover results in the presence of GTGT-containing NCF1B and NCF1C and ∆GT-containing NCF1 (Fig. 3a) 11, 12 . To obtain the correct genotypes for NCF1 variants, we specifically amplified the NCF1 sequence using PCR targeting GTGT (Supplementary Fig. 2 ) and measured the ∆GT/GTGT ratio by real-time PCR to exclude subjects carrying GTGT-containing NCF1B and NCF1C (3:3 or 2:4 ratio) or ∆GT-containing NCF1 (5:1 ratio) (Fig. 3b,c) . Using this approach followed by Sanger sequencing, we resequenced the entire 15.5-kb NCF1 region in 45 Chinese subjects and identified 67 SNPs (Supplementary Table 6 ). Of these SNPs, only two encoding p.Arg90His (rs201802880) and p.Ser99Gly (rs17295741) in exon 4 and two intronic SNPs (intronic-1 (without a dbSNP ID) and intronic-2 (rs199789198)) of NCF1 showed r 2 > 0.1 with rs117026326. We hypothesized that at least one of these four NCF1 SNPs was the causal variant tagged by rs117026326 in Chinese and shared by European and African Americans and that the causal SNP(s) might be located by leveraging the different LD patterns in these ancestry groups.
LD analysis in African Americans suggested that either p.Arg90His or p.Ser99Gly might be the causal variant because intronic-1 and intronic-2 were in complete LD with non-polymorphic rs117026326 (Fig. 1c) . To confirm this, we assessed these four variants, by performing l e t t e r s nested PCR and TaqMan assays and measuring the ∆GT/GTGT ratio, for association with SLE in African Americans. Of the variants, only p.Arg90His was associated with SLE (15.7% versus 8.3%, P = 2.9 × 10 −5 , OR = 2.02; Table 1 and Supplementary Table 5 ). As expected, intronic-1 and intronic-2 were nearly non-polymorphic and were not associated with SLE in African Americans, suggesting that they might not be the causal variant shared by different ancestry groups, and they were excluded in subsequent analyses. Next, we assessed p.Arg90His and p.Ser99Gly for association with SLE in Asians and European Americans. In two Chinese data sets and one Korean data set, p.Arg90His exhibited stronger association with SLE (Chinese-1: 38.1% versus 15.6%, P = 2.6 × 10 −23 , OR = 3.35; Chinese-2: 41.6% versus 16.7%, P = 1.5 × 10 −41 , OR = 3.27; Korean: 46.6% versus 18.1%, P = 2.6 × 10 −43 , OR = 3.82; P meta Asian = 3.1 × 10 −104 , OR = 3.47; Table 1 and Supplementary Table 3 ) than p.Ser99Gly, and conditioning on p.Arg90His eliminated association signals detected at p.Ser99Gly and the GTF2IRD1-GTF2I region. In two European-American data sets, p.Arg90His consistently showed stronger association with SLE (EurAm-1: 5.5% versus 2.1%, P = 9.5 × 10 −5 , OR = 2.83; EurAm-2: 6.0% versus 2.4%, P = 5.0 × 10 −4 , OR = 2.42; l e t t e r s P meta EurAm = 1.9 × 10 −7 , OR = 2.61; Fig. 3 ). These data support p.Arg90His as a likely causal variant for SLE susceptibility shared across Asian, European-American and African-American populations within the GTF2IRD1-GTF2I-NCF1 region.
In addition to SLE, p.Arg90His was associated with other autoimmune diseases, including primary Sjögren's syndrome (MIM 270150) in Chinese (37.8% versus 18.3%, P = 7.2 × 10 −17 , OR = 2.45) and European Americans (4.8% versus 2.2%, P = 9.7 × 10 −4 , OR = 2.35; Table 1 and Supplementary Table 7) , which explains the reported association of rs117026326 with Sjögren's syndrome in Chinese 13 , and seropositive rheumatoid arthritis (MIM 180300) in Koreans (26.6% versus 18.1%, P = 2.5 × 10 −8 , OR = 1.65; Table 1 and Supplementary  Table 8 ), but with a modest effect size.
Arg90 of p47 phox , located in a phosphoinositide-binding pocket of the PX domain, has a crucial role in the membrane translocation of cytosolic p47 phox and resultant activation of NOX2 for ROS production 14 . The substitution of evolutionarily conserved Arg90 with a histidine residue encoded by the SLE risk allele was predicted to be deleterious ( Supplementary Fig. 4 ), a prediction that is supported by in vitro mutation studies indicating that changing Arg90 to histidine 2 , or to lysine, leucine or alanine [14] [15] [16] , reduces ROS production. These data suggest that p.Arg90His might confer risk for SLE by reducing NOX2-derived ROS levels. Consistent with this idea, the SLE risk allele encoding p.His389Gln in p67 phox causes reduced ROS production in transfection assays 8 . However, p.Arg90His was not associated with intracellular ROS levels in neutrophils from controls ( Supplementary  Fig. 5 ), probably because of the impact of mitochondrial ROS 17 .
The GTGT to ΔGT mutation in NCF1 (rs273585651) leads to a frameshift and a premature stop codon at residue 51 (Fig. 2b) (ref. 11) . Because of an absence of functional p47 phox and failure of ROS production, homozygous carriers of ΔGT in NCF1 develop a rare disease, chronic granulomatous disease (CGD), and have increased risk of developing SLE (Fig. 3a) (ref. 7) . NCF1B and NCF1C are transcribed but do not produce functional protein because they contain ΔGT 10 . However, GTGT-containing NCF1B and NCF1C are believed to produce intact p47 phox similar to functional NCF1, although this has not yet been experimentally validated 12 . Analyzing the ∆GT/GTGT ratio allowed us to assess copy number variation (CNV) in NCF1. One copy of NCF1 (5:1 ratio) was associated with increased risk of SLE in Koreans (P = 0.032), Chinese (P = 0.011) and European Americans (P = 5.9 × 10 −4 , OR = 3.91; Supplementary Table 9 ). In contrast, having ≥3 copies of NCF1 (3:3 and 2:4 ratios) was protective against developing SLE in Koreans (P = 3.7 × 10 −5 ), Chinese (P = 2.8 × 10 −3 , OR = 0.28), European Americans (P = 0.038, OR = 0.85) and African Americans (P = 0.018, OR = 0.73). These data support the notion that reduced ROS production is a risk factor for SLE. Association between CNV of NCF1 and Sjögren's syndrome was not detected in European Americans, probably owing to the limited sample size.
ROS can be a double-edged sword in autoimmunity. High levels of ROS, predominantly produced by NOX2 in phagocytes for host defense, may lead to inflammatory tissue damage, but ROS are also signaling molecules regulating T cell differentiation, B cell proliferation and antigen processing in dendritic cells 18 . Our findings suggest that reduced NOX2-derived ROS production increases the risk of developing autoimmune diseases, consistent with previous reports 2,6-8 , but the underlying mechanism remains elusive. 19 and nonfunctional NOX2 causes defective clearance of dying cells and lupus-like phenotypes 20 , providing a possible explanation for the pathogenic role of reduced ROS levels in SLE.
Of note, NCF1 variants have not been correctly called in studies using short sequence reads, such as the 1000 Genomes Project (Supplementary Fig. 6 ) and the Exome Aggregation Consortium, owing to the presence of NCF1B and NCF1C. Consequently, we would like to emphasize that NCF1 variants need to be assessed with great caution to exclude the impact of NCF1B and NCF1C. In this study, we identified p.Arg90His by NCF1-specific PCR and Sanger sequencing. However, because of the complexity of this region and the difficulty of long-range PCR, we only resequenced NCF1 in Chinese subjects, and potential causal variants within the NCF1-neighboring region or specific for European and African Americans might not have been discovered. Given that most lupus-associated variants show OR <2 in GWAS 21 , the chance of finding a causal variant within the noncoding region of NCF1 that can explain the association of p.Arg90His with SLE (OR > 3 in Asians and OR > 2 in European and African Americans) is small. Although we cannot exclude the possibility of additional causal NCF1 variants, their association with SLE should be independent from that of p.Arg90His.
In summary, we identify a p.Arg90His substitution encoded in NCF1 as a novel risk variant for SLE, Sjögren's syndrome and rheumatoid arthritis, and we show that decreased and increased copy numbers of NCF1 predispose to and protect against SLE, respectively. Our data highlight the pathogenic role of reduced ROS production in autoimmune diseases and indicate the presence of missing heritability within complex genomic regions.
URLs. 1000 Genomes Project, http://www.1000genomes.org/; RegulomeDB, http://www.regulomedb.org/; PLINK, http://pngu.mgh. harvard.edu/~purcell/plink; SNPTEST, https://mathgen.stats.ox.ac. uk/genetics_software/snptest/snptest.html; Haploview, https://www. broadinstitute.org/haploview/haploview; EIGENSOFT, https://www. hsph.harvard.edu/alkes-price/software; UCSC Genome Browser, http://genome.ucsc.edu/.
MEtHODS
Methods, including statements of data availability and any associated accession codes and references, are available in the online version of the paper. 
ONLINE MEtHODS
Subjects. Discovery stage. Patients with SLE and healthy controls in the discovery stage were recruited from the University of California Los Angeles (UCLA), the Oklahoma Medical Research Foundation (OMRF) and the Medical University of South Carolina (MUSC). All patients with SLE met at least 4 of the 11 American College of Rheumatology (ACR) criteria for the classification of SLE 22 . The final data set after quality control comprised subjects from three different ancestry groups, including Chinese (1,010 cases and 848 controls recruited from UCLA), African Americans (532 cases and 367 controls recruited from OMRF and MUSC) and European Americans (930 cases and 1,107 controls recruited from UCLA and OMRF). All these samples were genotyped using the Immunochip, and we estimated that there was power of >90% to identify an SLE-associated variant with MAF >10% and OR >2.0 at the GWAS significance level of P < 5 × 10 −8 in Chinese and European Americans. Of the subjects, all African Americans and a subset of the Chinese (441 cases and 589 controls; data set Chinese-1) and European Americans (716 cases and 578 controls; data set EurAm-1) were genotyped using TaqMan assays for SNPs not included on the Immunochip.
Replication stage. To replicate the result in data set Chinese-1, an independent cohort comprising 746 Chinese SLE cases and 1,034 healthy Chinese controls (data set Chinese-2) was recruited from Shanghai Renji Hospital. In addition, another Asian replication cohort comprising 614 Korean SLE cases and 692 healthy Korean controls was recruited from the Hanyang University Hospital for Rheumatic Diseases (HUHRD). To replicate the result in data set EurAm-1, an independent European-American cohort comprising 875 SLE cases and 540 healthy controls (data set EurAm-2) was recruited from UCLA, MUSC and OMRF.
To assess p.Arg90His and p.Ser99Gly for association with other autoimmune diseases, 863 Korean patients with rheumatoid arthritis were recruited from HUHRD. All patients with rheumatoid arthritis were positive for antibodies to citrullinated peptide and fulfilled the ACR 1987 revised criteria for the classification of rheumatoid arthritis 23 . In addition, 382 EuropeanAmerican patients with primary Sjögren's syndrome, described in a previous GWAS 24 , were recruited from OMRF and 449 Chinese patients with Sjögren's syndrome and 469 healthy Chinese controls were recruited from Peking University People's Hospital. All patients with Sjögren's syndrome fulfilled the American-European Consensus Group (AECG) criteria for primary Sjögren's syndrome 25 .
To measure the ∆GT/GTGT ratio, additional Chinese (198 patients with SLE and 471 controls recruited from the First Affiliated Hospital of Nanjing Medical University), African Americans (184 patients with SLE and 39 controls) and Koreans (215 patients with SLE and 90 controls) were used, but these subjects were not genotyped for SNPs.
Each participating institution had institutional review board (IRB) approval to recruit subjects. All subjects provided written informed consent.
Immunochip genotyping and quality control. Samples in the discovery stage were genotyped using the Immunochip according to Illumina's protocols at the University of Texas Southwestern Medical Center, HudsonAlpha or OMRF, and all samples were reclustered for genotype calling as a single project at OMRF.
We excluded SNPs with a call rate <95% in cases or controls and removed samples with a SNP call rate <90%. SNPs were also excluded if they showed deviation from Hardy-Weinberg equilibrium (P HWE < 0.001 in controls, P HWE < 0.00001 in cases) or they had significantly different call rates in cases and controls (call rate < 98% and P < 0.05). On the basis of the remaining SNPs, we identified related samples (shared identity by descent (PI_HAT) > 0.25; estimated using PLINK v1.07) and samples showing mismatch between the reported and estimated sex and excluded them from subsequent analyses. To identify ancestry outliers, the remaining samples were assessed by principal-component analysis (implemented in EIGENSOFT 4.2) based on 7,500 randomly selected autosomal SNPs with MAF >1%, low LD (r 2 <0.1 with each other) and no evidence of association with SLE (P > 0.01), and 1000 Genomes Project samples were used as reference populations (including 286 Asians (97 CHB, 100 CHS, 89 JPT), 379 Europeans (85 CEU, 98 TSI, 89 GBR, 93 FIN, 14 IBS) and 246 Africans (88 YRI, 61 ASW, 97 LWK)) (Supplementary Fig. 7) . Outliers of each ancestry (>6 s.d. from the mean principal component) were excluded. Principal components showing significant differences between cases and controls were included as covariates in the association test.
The Korean samples were analyzed in an independent Immunochip study and a GWAS 5, 26 . Principal components for the Korean samples were obtained from these two studies.
